Concepedia

Barbara Degar

BD

29

Publications

3.7K

Citations

25

H-Index

1994

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Boston Children's Hospital

Harvard University

Brigham and Women's Hospital

Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Barbara Degar is an author at Dana-Farber Cancer Institute specializing in medicine, hematology, and immunology.

ORCID

Top concepts

Publications per year

1994–2024

29

Publications

29

Recurrent BRAF mutations in Langerhans cell histiocytosis

Gayane Badalian‐Very, Jo‐Anne Vergilio, Barbara Degar et al. · Blood · 2010 · 1.2K citations

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial

Jeffrey E. Rubnitz, Hiroto Inaba, Gary V. Dahl et al. · The Lancet Oncology · 2010 · 571 citations

, , +8

Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

Franco Locatelli, Michael B. Jordan, Carl E. Allen et al. · New England Journal of Medicine · 2020 · 480 citations · Full text

Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia

Hiroto Inaba, Elaine Coustan‐Smith, Xueyuan Cao et al. · Journal of Clinical Oncology · 2012 · 206 citations · Full text

Mutations of the hemophagocytic lymphohistiocytosis–associated gene <i>UNC13D</i> in a patient with systemic juvenile idiopathic arthritis

Melissa M. Hazen, Amy Woodward, Inga Hofmann et al. · Arthritis & Rheumatism · 2008 · 111 citations

Rows per page

1–5 of 29